FXR: a metabolic regulator and cell protector

被引:306
作者
Wang, Yan-Dong [1 ]
Chen, Wei-Dong [1 ]
Moore, David D. [2 ]
Huang, Wendong [1 ]
机构
[1] City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Duarte, CA 91010 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
FXR; bile acid; metabolism; liver regeneration; hepatocarcinogenesis;
D O I
10.1038/cr.2008.289
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. As a metabolic regulator, FXR plays key roles in bile acid, cholesterol, lipid, and glucose metabolism. Therefore, FXR is a potential drug target for a number of metabolic disorders, especially those related to the metabolic syndrome. More recently, our group and others have extended the functions of FXR to more than metabolic regulation, which include anti-bacterial growth in intestine, liver regeneration, and hepatocarcinogenesis. These new findings suggest that FXR has much broader roles than previously thought, and also highlight FXR as a drug target for multiple diseases. This review summarizes the basic information of FXR but focuses on its new functions.
引用
收藏
页码:1087 / 1095
页数:9
相关论文
共 84 条
  • [61] Farnesoid X receptor regulates bile acid-amino acid conjugation
    Pircher, PC
    Kitto, JL
    Petrowski, ML
    Tangirala, RK
    Bischoff, ED
    Schulman, IG
    Westin, SK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27703 - 27711
  • [62] PREVALENCE OF HEPATOCELLULAR-CARCINOMA IN ALPHA-1-ANTITRYPSIN DEFICIENCY
    PROPST, T
    PROPST, A
    DIETZE, O
    JUDMAIER, G
    BRAUNSTEINER, H
    VOGEL, W
    [J]. JOURNAL OF HEPATOLOGY, 1994, 21 (06) : 1006 - 1011
  • [63] Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
    Sakurai, Toshiharu
    Maeda, Shin
    Chang, Lufen
    Karin, Michael
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (28) : 10544 - 10551
  • [64] Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection
    Shibata, M
    Morizane, T
    Uchida, T
    Yamagami, T
    Onozuka, Y
    Nakano, M
    Mitamura, K
    Ueno, Y
    [J]. LANCET, 1998, 351 (9118) : 1773 - 1777
  • [65] Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
    Sinal, CJ
    Tohkin, M
    Miyata, M
    Ward, JM
    Lambert, G
    Gonzalez, FJ
    [J]. CELL, 2000, 102 (06) : 731 - 744
  • [66] The farnesoid X receptor induces very low density lipoprotein receptor gene expression
    Sirvent, A
    Claudel, T
    Martin, G
    Brozek, J
    Kosykh, V
    Darteil, RL
    Hum, DW
    Fruchart, JC
    Staels, B
    [J]. FEBS LETTERS, 2004, 566 (1-3): : 173 - 177
  • [67] Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor
    Song, CS
    Echchgadda, I
    Baek, BS
    Ahn, SC
    Oh, T
    Roy, AK
    Chatterjee, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) : 42549 - 42556
  • [68] Regulation of carbohydrate metabolism by the farnesoid X receptor
    Stayrook, KR
    Bramlett, KS
    Savkur, RS
    Ficorilli, J
    Cook, T
    Christe, ME
    Michael, LF
    Burris, TP
    [J]. ENDOCRINOLOGY, 2005, 146 (03) : 984 - 991
  • [69] The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression
    Swales, Karen E.
    Korbonits, Marta
    Carpenter, Robert
    Walsh, Desmond T.
    Warner, Timothy D.
    Bishop-Bailey, David
    [J]. CANCER RESEARCH, 2006, 66 (20) : 10120 - 10126
  • [70] Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease
    Ueno, Y
    Moriyama, M
    Uchida, T
    Arakawa, Y
    [J]. HEPATOLOGY, 2001, 33 (02) : 357 - 362